Cox regression analysis revealed that male BC cohort had poorer OS than the female BC group in both HoR+/HER2− (Figure 5B, p < 0.001) and HoR+/HER2+ group (Figure 5C, p = 0.003). The gene discussed is ERBB2; the disease is breast cancer.